BridgeMD
New treatment option for Ovarian Cysts
Official title Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts
ClinicalTrials.gov ID: NCT07686783
What this study is testing
- What it's testing
- We will conduct this study to estimate the effect of laparoscopic cystectomy on ovarian reserve in endometriotic cysts versus non-endometriotic cysts.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Female patients aged 18-45 years
- Ovarian cyst measuring 6-15 cm in diameter, confirmed by transvaginal ultrasound or MRI
- Cyst is persistent for more than 3 months if asymptomatic, OR any symptomatic cyst regardless of duration of diagnosis
- Serum anti-Müllerian hormone (AMH) level ≥ 2 ng/mL, measured within 1 month preoperatively
- Willingness to participate and provide written informed consent
You likely can't join if
- Clinical or ultrasonic suspicion of ovarian malignancy
- Ovarian cyst associated with pregnancy
- Previous history of ovarian surgery
- History of pelvic irradiation or chemotherapy
- Known endocrine disorders affecting ovarian function (e.g., PCOS, premature ovarian insufficiency, thyroid dysfunction, hyperprolactinemia)
- Current use of hormonal contraceptives or hormonal therapy within 3 months prior to enrollment
See the full eligibility criteria
- Female patients aged 18-45 years
- Ovarian cyst measuring 6-15 cm in diameter, confirmed by transvaginal ultrasound or MRI
- Cyst is persistent for more than 3 months if asymptomatic, OR any symptomatic cyst regardless of duration of diagnosis
- Serum anti-Müllerian hormone (AMH) level ≥ 2 ng/mL, measured within 1 month preoperatively
- Willingness to participate and provide written informed consent
- Clinical or ultrasonic suspicion of ovarian malignancy
- Ovarian cyst associated with pregnancy
- Previous history of ovarian surgery
- History of pelvic irradiation or chemotherapy
- Known endocrine disorders affecting ovarian function (e.g., PCOS, premature ovarian insufficiency, thyroid dysfunction, hyperprolactinemia)
- Current use of hormonal contraceptives or hormonal therapy within 3 months prior to enrollment
- Presence of severe systemic disease that contraindicates surgery or general anesthesia
- Refusal to participate or inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Banhā, Qalyubia Governorate, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banhā, Qalyubia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.